Conference Coverage

VIDEO: Addiction-treatment workforce too small to cope with demand


 

AT THE SUMMIT IN NEUROLOGY & PSYCHIATRY

References

WASHINGTON – “No one would say the reversal of the medical effects of [illicit drug use] is ‘treatment,’ ” says Dr. Mark S. Gold, an addiction specialist in the department of psychiatry at Washington University in St. Louis. That’s only the beginning, he says. After patients with drug addictions are stabilized, then begins the complicated and lengthy task of treatment. Yet, there is a coming shortage of medical personnel qualified to offer addiction treatment, says Dr. Gold, who cites that – in the next decade – the addiction-treatment workforce will be 10 times too small to meet the demand. In this video, recorded at the Summit in Neurology & Psychiatry held by the Global Academy for Medical Education, Dr. Gold discusses ways that primary care physicians and others can help. The Global Academy and this news organization are owned by the same company.

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel.

wmcknight@frontlinemedcom.com

On Twitter @whitneymcknight

Recommended Reading

Poison center calls for fake pot up 330% in first half of 2015
MDedge Internal Medicine
‘Dabbing’ on the rise: Is this marijuana use dangerous?
MDedge Internal Medicine
ICOO: Quality metrics needed for medical marijuana
MDedge Internal Medicine
ICOO: Opioids blurring criminal activity and malpractice
MDedge Internal Medicine
To sleep, perchance to reprogram behaviors?
MDedge Internal Medicine
Legislation aims to improve treatment of serious mental illness
MDedge Internal Medicine
Morphine synthesis finding paves way for new painkillers
MDedge Internal Medicine
WCD: Smoking tied to worse occupational hand eczema
MDedge Internal Medicine
VIDEO: Beware of dehydration, hyperthermia in drug-taking concert-goers, or ‘ravers’*
MDedge Internal Medicine
VIDEO: Watch for anxiety, other symptoms in cannabis users on anti-cannabinoids
MDedge Internal Medicine